Owner FEED Investor / Financier Operator Developer Offtaker Technology licensor Technology / equipment supplier
Evonik Industries AG is a specialty chemicals company headquartered in Essen, Germany, with global operations. It develops and manufactures materials, additives, and ingredients used across industrial and consumer markets, including coatings and adhesives, plastics and rubber, construction, automotive and aerospace, personal and home care, animal nutrition, healthcare, electronics, and energy.
Evonik’s portfolio includes high-performance polymers, silica and silicates, catalysts, specialty surfactants and care ingredients, crosslinkers and coating additives, membranes and resins, as well as feed additives and biotechnology-based solutions. The company operates an international production and R&D network and focuses on resource efficiency, safety, and sustainability in product development and manufacturing. Its activities are organized around specialty businesses such as Specialty Additives, Nutrition & Care, Smart Materials, and related performance materials. Subsidiary and business-line names seen in the market include Evonik Care Solutions, Evonik Vland Biotech, and Evonik Oxeno GmbH.
Also known as Evonik Oxeno GmbH, Evonik Oxeno, Evonik Vland Biotech, Evonik Vland, Evonik Care Solutions and 1 more.
chemXplore tracks 49 projects involving Evonik, of which 14 are active.
Besides these 14, the record holds 34 completed projects and 1 cancelled.
Closest to start-up first.
8 more active projects and the 35 that are completed, on hold or cancelled are in the record. See all 49 in chemXplore →
4 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.
Pilot will collect post-consumer and post-industrial foam, chemically hydrolyse it to recover high-purity polyols and amines as drop-in feedstock, and assess commercial scale-up in Japan.
New polymethacrylate excipients aim to keep solubility and delayed‑release performance while meeting OECD biodegradability criteria; lab‑scale material available for partner projects.
Acknowledges ongoing exploratory discussions; outcome remains uncertain. Says it will disclose material developments promptly under regulatory rules.
Aligns businesses by role, assigns roles to six German sites, and shifts investment to Asia/Americas; launches growth projects in Canada and Slovakia, funded by cost cuts.
Three biogas-to-biomethane upgrades across Germany, capacities 200–475 Nm³/h now, Friesoythe expandable to 600 Nm³/h; Delbrück first feed-in targeted for November.
EUR 80m upgrade adds downstream fermentation capacity for complex pharma intermediates, targets completion early 2028 and about 50 new jobs; site runs on 100% green electricity.
Around 90 employees affected; Hamburg roles to shift to Essen, Bitterfeld closure set for end‑April 2027; customer supply to larger German sites; employee talks planned.
SGT-800 demonstrator will run four years at Marl Chemical Park to validate blades, burners and additive-manufactured parts under real plant conditions while supplying power and steam.
active all projects
The 8 with the most active projects, of 9 countries.
What each is building and closing, and the pipelines and grids between them, on one map.
The 6 sharing the most projects, of 23.
The most active first. active / all projects
